Lightpoint Medical is a technology company that is a pioneer in developing and marketing precision-guided cancer surgery. Surgeons aren't able to see if the cancerous tissue has been removed in its entirety or not during a surgery. To better this situation, the company has developed an imaging technology based on PET radiopharmaceuticals, more precisely, Cerenkov Luminescence Imaging (CLI), which helps surgeons to detect cancer in a real-time during surgery. The company's first product has received marketing authorisation, i.e., the CE (European Conformity) Mark. A second product, a laparoscopic device for prostate cancer is in development. A non-clinical device has also been released. For its efforts, Lightpoint Medical won the 'Best in Show' Award at the 2014 MedTech Investing Europe Conference. The company aims to utilise the investment to scale its business.
days to go:
Expired
investment:
Withheld
Polysolar aims to transform buildings and transport infrastructure into self-generating power stations by substituting conventional construction materials with solar glazing panels. Its customers include Sainsbury’s and Canary Wharf. The company estimates the crossover Building-integrated Photovoltaics (BIPV) glass market worth $4 billion and aims to be a strong contender in this segment. Polysolar successfully raised £1.3 million on Crowdcube in 2018. It is in the final stages to secure a supply & install agreement with E.ON SE. It also won tenders for installing Electric Vehicle (EV) charging hubs from South Gloucester CC and Lake District National Park Authority. The company will use the investment to commercialise the immediate and significant opportunity in EV charging solar canopies and carports.
days to go:
Expired
investment:
£1,268,410
Molecular Warehouse are trying to create a world where most diseases are prevented by giving people the chance to monitor and manage their helath where ever and whenever. Molecular Warehouse have developed a platform that allows anyone to test themselves at any time.
days to go:
Expired
investment:
£737,480
At Showersave we believe in keeping things simple because simplicity is the key to any of the world’s greatest innovations. That’s why in creating Showersave we focused purely on creating a simple device that would deliver real energy saving results.
days to go:
Expired
investment:
£78,220
Buildy is an online platform that aims at making construction hiring easy by eliminating the expensive middlemen, thereby, saving time and money for both employers and employees. The platform was shortlisted as the Best Recruitment Innovation at Building Innovation Awards. Buildy has already signed up around 100 tradespeople and 46 employers. The company will streamline the hiring process through automation of job by bidding for jobs, matching algorithms, ratings, online chat, reviews, and providing the skilled workers and tradespeople more control via a better user interface. With the proceeds, the company will seek to fast track the Buildy app and help the company become the top recognised brand in construction staff hiring.
days to go:
Expired
investment:
£17,380
H2GO Power is a clean technology company that develops green technology using its proprietary hydrogen storage technology and AI platform. It aims to be a contender in the $117.49 (USD) billion global hydrogen generation market. The company has successfully tested drone flights with its technology and secured funding for second-generation manufacture and flight trials for drone storage systems and working on delivery. H2GO Power has also developed a partnership with the noted organisation, Autodesk. The company's CEO was featured by The Financial Times in its 'Top 100 influential Woman in Engineering in the UK and Europe' post. It has also received acclaims from the World Economic Forum (WEF), the MIT Technology Review and received the 'Best Energy Start-Up Award' at the Global Hello Tomorrow Summit, amongst other commendations. H2GO Power will use the investment to provide clean and reliable power from renewable sources to millions worldwide.
days to go:
Expired
investment:
£2,499,999
MGN Builders Merchants is a well-established, profitable, and a fast-growing builders merchants and skip hire based in London and Essex. It offers same or next day delivery on thousands of building products kept in stock at all times. Having served 50,000+ customers in 2018 (81k EBITDA), the company's client base includes small to medium-sized companies, private developers and DIY customers. In the last three years, the company has trebled its revenue from £2.5m in 2016 to £7m by January 2019, achieving an almost 100% sales increase YoY. MGN is raising funding to accelerate its rapid growth plans, expand its team, start selling online, and launch concrete delivery service to capture UK's £34bn construction supplied wholesale market.
days to go:
Expired
investment:
£114,260
Aiming to prevent further deterioration and leakage of water and sewerage pipes, Aqualiner has developed their Melt in Place Pipe (MIPP). This patented technology consists of a sock insertion, which when heated, expands and melts onto the inner pipe and forms a solid glass-reinforced thermoplastic layer. This process can increase the longevity of existing pipes and is the only product of this type to be approved to be safe-for-use in drinking water pipes. The UK has more than 251,000 miles of water pipes, where almost 75,000 miles of pipes are classed as damaged.
Aqualiner firstly plans to sell the initial equipment in return for a small profit margin, but the materials and consumables used in the process will be sold to the licensed contractor directly as a second income stream. The third source of revenue is derived from fees charged to International territorial licensors for any Aqualiner sales.
The product has been developed with support from Anglian Water, Severn Trent Water and Yorkshire Water and is approved to be installed in US drinking water pipes.
days to go:
Expired
investment:
£642,471
Arcis Biotechnology provide nucleic acid sample preparation solutions. They have made the process of obtaining genetic material from biological samples less time consuming so it can be done in less than 3 minutes.
days to go:
Expired
investment:
£1,146,318
C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.
days to go:
Expired
investment:
£211,595
